Related Experiment Video
Updated: Feb 4, 2026

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
Published on: June 30, 2014
Modulation of proteoglycan receptor PTPσ enhances MMP-2 activity to promote recovery from multiple sclerosis
Fucheng Luo1, Amanda Phuong Tran2, Li Xin1
1Department of Neurology, Case Western Reserve University School of Medicine, Cleveland, OH, 44106, USA.
Abstract:
Multiple Sclerosis (MS) is characterized by focal CNS inflammation leading to the death of oligodendrocytes (OLs) with subsequent demyelination, neuronal degeneration, and severe functional deficits. Inhibitory chondroitin sulfate proteoglycans (CSPGs) are increased in the extracellular matrix in the vicinity of MS lesions and are thought to play a critical role in myelin regeneration failure. We here show that CSPGs curtail remyelination through binding with their cognate receptor, protein tyrosine phosphatase σ (PTPσ) on oligodendrocyte progenitor cells (OPCs). We report that inhibition of CSPG/PTPσ signaling by systemically deliverable Intracellular Sigma Peptide (ISP), promotes OPC migration, maturation, remyelination, and functional recovery in animal models of MS. Furthermore, we report a downstream molecular target of PTPσ modulation in OPCs involving upregulation of the protease MMP-2 that allows OPCs to enzymatically digest their way through CSPGs. In total, we demonstrate a critical role of PTPσ/CSPG interactions in OPC remyelination in MS.
Insights
Inhibiting chondroitin sulfate proteoglycans (CSPGs) and protein tyrosine phosphatase sigma (PTPσ) signaling with Intracellular Sigma Peptide (ISP) promotes myelin repair and functional recovery in animal models of Multiple Sclerosis (MS). This approach aids oligodendrocyte progenitor cell (OPC) migration and maturation.
Area of Science:
- Neuroscience
- Immunology
- Regenerative Medicine
Background:
- Multiple Sclerosis (MS) involves central nervous system (CNS) inflammation, oligodendrocyte (OL) death, and demyelination, leading to functional deficits.
- Increased inhibitory chondroitin sulfate proteoglycans (CSPGs) in MS lesions impede myelin regeneration.
- CSPGs exert their inhibitory effects by binding to their receptor, protein tyrosine phosphatase sigma (PTPσ), on oligodendrocyte progenitor cells (OPCs).
Purpose of the Study:
- To investigate the role of CSPG/PTPσ signaling in failed remyelination in MS.
- To evaluate the therapeutic potential of inhibiting CSPG/PTPσ interactions for promoting myelin repair in MS models.
Main Methods:
- Utilized animal models of MS.
- Administered systemically deliverable Intracellular Sigma Peptide (ISP) to inhibit CSPG/PTPσ signaling.
- Assessed OPC migration, maturation, and remyelination.
- Analyzed downstream molecular targets, including matrix metalloproteinase-2 (MMP-2).
Main Results:
- Inhibition of CSPG/PTPσ signaling by ISP significantly promoted OPC migration, maturation, and remyelination in MS models.
- ISP treatment led to functional recovery in animal models of MS.
- PTPσ modulation resulted in the upregulation of MMP-2, facilitating CSPG digestion by OPCs.
Conclusions:
- CSPG/PTPσ interactions critically inhibit OPCs and impede remyelination in MS.
- Targeting CSPG/PTPσ signaling with ISP represents a promising therapeutic strategy for promoting myelin repair and functional recovery in MS.
Related Concept Videos
Proteoglycans
Internal Receptors
Matrix Proteoglycans and Glycoproteins
The Eukaryotic Promoter Region
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Co-activators and Co-repressors

